Actinogen Medical Ltd

3AC-FF:Frankfurt Stock Exchange
RT Quote | Exchange | EUR
Last | 01/22/21 CET
0.009UNCH (UNCH)
52 week range
0.01 - 0.02

...

Loading . . .

KEY STATS

  • Open0.009
  • Day High0.009
  • Day Low0.009
  • Prev Close0.009
  • 52 Week High0.02
  • 52 Week High Date01/12/21
  • 52 Week Low0.01
  • 52 Week Low Date01/06/21
  • Market Cap19.32M
  • Shares Out1,139.01M
  • 10 Day Average Volume6,666.67
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-54.08

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Actinogen Medical Ltd News

There is no recent news for this security.

Latest 3AC-FF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Actinogen Medical Limited, formerly Actinogen Limited, is a clinical-stage biotechnology company. The Company focuses on the treatment of Alzheimer's disease and age-related neurodegenerative diseases. The Company is engaged in treating cognitive impairment in chronic neurodegenerative diseases through the inhibition of cortisol production. The Company's Xanamem is a drug under development for the treatment of Alzheimer's disease, which is designed to block the production of...
Geoffrey Brooke M.D.
Chairman
John Ketelbey
Chief Executive Officer
Jeff Carter
Chief Financial Officer
Address
Select House
SE 901 L 9, 109 Pitt Street
Sydney, NSW
2000
Australia